SCHEMBL17291698

SCHEMBL17291698

CC(C)(C)OCC(NC=O)C(=O)OC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CTSK P43235 5/20 0.36
▸ GRN P28799 1/20 0.35
▸ SORT1 Q99523 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ POLB P06746 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ ITGA4 P13612 1/20 0.32
▸ ITGB7 P26010 1/20 0.32
▸ MAPK14 Q16539 1/20 0.31
▸ CA1 P00915 1/20 0.30
▸ CA2 P00918 1/20 0.30
▸ CA7 P43166 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ CYP2C9 P11712 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30
▸ HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4706854 0.82 CTSK (0.40) CTSKPOLBNPSR1TDP1ITGA4
SCHEMBL7158828 0.81 MAPK1 (0.36) CTSKGRNSORT1MAPK1
Fluoride SCHEMBL7158831 0.81 GRN (0.46) CTSKGRNSORT1MAPK1CYP2C9
SCHEMBL29022125 0.81 CTSK (0.34) CTSKPOLBNPSR1TDP1ITGA4
SCHEMBL13925605 0.79 CYP2D6 (0.40) CTSKPOLBNPSR1TDP1ITGA4
SCHEMBL13925615 0.79 NPSR1 (0.45) CTSKMAPK1POLBNPSR1TDP1
SCHEMBL13993198 0.79 GRN (0.43) CTSKGRNSORT1MAPK1POLB
SCHEMBL22262968 0.79 MAPK1 (0.38) CTSKGRNSORT1MAPK1POLB
SCHEMBL23051973 0.77 GRN (0.39) CTSKGRNSORT1MAPK1POLB
SCHEMBL25453637 0.77 MAPK1 (0.41) CTSKGRNSORT1MAPK1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150344404-A1 PDK4 INHIBITOR AND USE THEREOF THE KITASATO INSTITUTE (JP) 2015-12-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150344404-A1 PDK4 INHIBITOR AND USE THEREOF PDK4, PDK3, PDK2 CTSK 816/4885GRN 3532/4885SORT1 4879/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback